News
Canada: TotalEnergies Signs an Agreement to Export 2 Mtpa of LNG for 20 Years From the Ksi Lisims LNG Project
TotalEnergies has signed a Sales and Purchase Agreement (SPA) with Ksi Lisims LNG for the purchase of 2 Mtpa of LNG for 20 years from the future liquefaction plant, subject to the final investment
Canada: TotalEnergies Signs an Agreement to Export 2 Mtpa of LNG for 20 Years From the Ksi Lisims LNG Project
TotalEnergies has signed a Sales and Purchase Agreement (SPA) with Ksi Lisims LNG for the purchase of 2 Mtpa of LNG for 20 years from the future liquefaction plant, subject to the final investment
FIGEAC AÉRO: FIGEAC AÉRO STREGNTHENS ITS POSITION ON A MAJOR NATIONAL SOVEREIGNTY PROGRAMME
Kaufman & Broad SA: ORDINARY AND EXTRAORDINARY SHAREHOLDERS' MEETING OF 2025, MAY 6TH - VOTING RESULTS
Biogas: TotalEnergies and HitecVision Partner to Pursue the Development of Polska Grupa Biogazowa in Poland
TotalEnergies (Paris:TTE) (LSE:TTE) (NYSE:TTE) has signed a Sale and Purchase Agreement (SPA) with HitecVision, a Norwegian investment company specializing in energy, for the sale of 50% of Polska
Biogas: TotalEnergies and HitecVision Partner to Pursue the Development of Polska Grupa Biogazowa in Poland
TotalEnergies (Paris:TTE) (LSE:TTE) (NYSE:TTE) has signed a Sale and Purchase Agreement (SPA) with HitecVision, a Norwegian investment company specializing in energy, for the sale of 50% of Polska
Biogas: TotalEnergies and HitecVision Partner to Pursue the Development of Polska Grupa Biogazowa in Poland
TotalEnergies (Paris:TTE) (LSE:TTE) (NYSE:TTE) has signed a Sale and Purchase Agreement (SPA) with HitecVision, a Norwegian investment company specializing in energy, for the sale of 50% of Polska
GenSight Biologics Announces Approval of All Resolutions Supported by the Board of Directors at the Combined General Meeting of May 13, 2025
Regulatory News:
The Combined General Meeting of shareholders of GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and
Poxel Reports Consolidated Revenue for the First Quarter 2025 and Provides Corporate Update
Regulatory News:
POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic
FIGEAC AÉRO: 10 JUNE 2025: RELEASE OF FULL-YEAR 2024/25 RESULTS
FIGEAC AÉRO: 2024/25 REVENUE TARGET ACHIEVED: €432.3M, REFLECTING 8.1% ORGANIC GROWTH FINANCIAL PERFORMANCE TARGETS REITERATED
Kaufman & Broad SA: DIVIDEND PAYMENT IN RESPECT OF THE FINANCIAL YEAR ENDED NOVEMBER 30, 2024
Kaufman & Broad SA: DESCRIPTION OF THE SHARE REPURCHASE PROGRAM 2025
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Oman: TotalEnergies and OQEP break ground at Marsa LNG
Under the patronage of His Excellency Eng. Salim bin Nasser Al Aufi, Minister of Energy & Minerals of the Sultanate of Oman, Patrick Pouyanné, Chairman and CEO of TotalEnergies (Paris:TTE)
Oman: TotalEnergies and OQEP break ground at Marsa LNG
Under the patronage of His Excellency Eng. Salim bin Nasser Al Aufi, Minister of Energy & Minerals of the Sultanate of Oman, Patrick Pouyanné, Chairman and CEO of TotalEnergies (Paris:TTE)
Oman: TotalEnergies and OQEP break ground at Marsa LNG
Under the patronage of His Excellency Eng. Salim bin Nasser Al Aufi, Minister of Energy & Minerals of the Sultanate of Oman, Patrick Pouyanné, Chairman and CEO of TotalEnergies (Paris:TTE)
TP Helps Organizations Adopt and Scale Agentic AI with Two New AI Partnerships
Regulatory News:
Global digital services leader TP (Paris:TEP) today announced partnerships with emerging leaders in agentic artificial intelligence (AI), Ema and Parloa. These partnerships
Teleperformance: Quarterly Information as of March 31, 2025
Regulatory News:
Teleperformance (TP) (Paris:TEP), a global leader in digital business services, recorded revenue of €2,613 million for the first-quarter 2025, up +2.8% as reported and +1.6%
EQS-News: Abivax Announces Completion of Enrollment for the Phase 3 ABTECT Trials in Patients with Moderately to Severely Active Ulcerative Colitis
Dassault Systèmes and Airbus Extend Strategic Partnership to Use Virtual Twins for Next-Generation Programs
Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) and Airbus have extended their long-term strategic partnership, putting the 3DEXPERIENCE platform at the heart of lifecycle management of
Dassault Systèmes and Airbus Extend Strategic Partnership to Use Virtual Twins for Next-Generation Programs
Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) and Airbus have extended their long-term strategic partnership, putting the 3DEXPERIENCE platform at the heart of lifecycle management of
GenSight Biologics Annual General Meeting on May 13, 2025
Regulatory News:
GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal
EQS-News: Abivax Announces Annual General Meeting Details as Company Advances Toward Key 2025 Value-Driving Milestones
EQS-News: Abivax Announces Appointment of Dominik Höchli, MD to Board of Directors